COVID-19 Vaccine Information Center

Case & Vaccine Monitoring ​

NDDoH Data Dashboard: Vaccines Administered & Case Counts

North Dakota Stories: COVID-19 Impact Wall

CDC Data Tracker: Vaccine Doses Administered in the US and by State

CDC COVID-19: News & Highlights 

About the COVID-19 Vaccine​

COVID-19 vaccines are safe and effective. Fully vaccinated individuals are significantly less likely to have symptomatic infection, severe disease, hospitalization, and reinfection from COVID-19 compared to nonvaccinated individuals. Getting vaccinated is the best way to protect ourselves and those around us from COVID-19. Read the latest studies. ​

Most people 5 years of age and older are eligible to be vaccinated against COVID-19. The Pfizer-BioNTech COVID-19 vaccine (known as Comirnaty, pronounded koe-mire'-na-tee) has full FDA approval for individuals 16 years of age and older. The Moderna vaccine (known as Spikevax) has full FDA approval for individuals 18 years of age and older.

The public can be very confident that these vaccines meet high standards for safety, effectiveness, and manufacturing quality . Read more about the FDA approval and the Biologics License Applications (BLA) process. 

Subscribe to Email Updates

​Vaccine Safety

While some people may experience mild symptoms after receiving the vaccine, serious adverse events appear to be rare. Medical providers and vaccine experts believe that the benefits of receiving the COVID-19 vaccine greatly outweigh the risks. ​

COVID-19 vaccines were studied in clinical trials in tens of thousands of people from diverse ages, races and ethnicities. Manufacturers had to meet rigorous safety and efficacy standards before their vaccines were authorized for use in the U.S. Today, hundreds of millions of people in the U.S. have received COVID-19 vaccines under the most intensive safety monitoring in our history – reassuring us that COVID-19 vaccines are safe and effective. ​

Learn More About COVID-19 Vaccine Safety

Available Vaccines & Eligibility 

​Currently, there are three COVID-19 vaccines authorized for use in the US: Moderna, Pfizer, and Johnson & Johnson (Janssen). Moderna and Pfizer’s COVID-19 vaccines are mRNA (messenger RNA) vaccines. Johnson & Johnson is a non-replicating viral vector vaccine. These vaccines teach your body to fight off COVID-19. Vaccines do not stick around in our body for long, nor do they give you COVID-19. Rather, if we come in contact with the virus that causes COVID-19, the vaccine has prepped our immune system to recognize the virus and fight off the infection more effectively. 

Most children and adults age 5 years and older are now eligible to receive the COVID-19 vaccine:

  • Pfizer-BioNTech (2 dose primary series, given 21 days apart) - Ages 5+
  • Moderna (2 dose primary series, given 28 days apart) - Ages 18+
  • Johnson & Johnson/Janssen (1 dose primary series) - Ages 18+

Some immunocompromised individuals should receive an additional dose of the vaccine to complete their primary series. All Pfizer-BioNTech vaccine recipients 12 years and older should receive a booster dose at least five months after their primary series. All Moderna recipients age 18 years and older should receive a booster dose at least five months after their primary series. All recipients of the Johnson & Johnson vaccine should receive a booster dose two months after their first dose. Click here for more information about booster doses. Some individuals, including those 65 years and older and/or immunocompromised, should receive a second booster dose four months after their first booster dose.

You are considered fully vaccinated after 2 weeks of your second dose. You are considered up-to-date after your booster dose.

Click here for a visual representation of Pfizer, Moderna, and Johnson & Johnson vaccine schedules.

Learn more about the COVID-19 Vaccine. 

Get Your Vaccine

COVID-19 Vaccine Locator or text GETVAX to 438829 to find a vaccine near you!


Top of page